Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults
Public ClinicalTrials.gov record NCT00772109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Lot Consistency, Immunogenicity, and Safety Study of Three Lots of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® Administered Intramuscularly in Adult Subjects Aged 18 to 64 Years
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to test lot consistency of three different manufacturing lots and to generate safety and immunogenicity data of the investigational vaccine administered via the ID route. Primary Objective: * To demonstrate lot consistency of the Fluzone ID manufacturing process. * To provide information concerning the immune response of Fluzone ID. Secondary Objectives: Safety * To describe the safety profile of subjects who receive of Fluzone ID.
Study identification
- NCT ID
- NCT00772109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,292 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- May 2009 (Actual)
- Completion
- Jul 2009 (Actual)
- Last update posted
- Apr 14, 2016
2008 – 2009
United States locations
- U.S. sites
- 46
- U.S. states
- 24
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hoover | Alabama | 35216 | — |
| Not listed | Huntsville | Alabama | 35802 | — |
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Mesa | Arizona | 85213 | — |
| Not listed | Phoenix | Arizona | 85014 | — |
| Not listed | Tucson | Arizona | 85711 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Milford | Connecticut | 06460 | — |
| Not listed | Melbourne | Florida | 32935 | — |
| Not listed | Pembroke Pines | Florida | 33024 | — |
| Not listed | Pinellas Park | Florida | 33781 | — |
| Not listed | Boise | Idaho | 83642 | — |
| Not listed | Chicago | Illinois | 60610 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Wichita | Kansas | 67207 | — |
| Not listed | Lexington | Kentucky | 40509 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Rockville | Maryland | 20850 | — |
| Not listed | Kansas City | Missouri | 64114 | — |
| Not listed | Springfield | Missouri | 65802 | — |
| Not listed | St Louis | Missouri | 63104 | — |
| Not listed | Albuquerque | New Mexico | 87108 | — |
| Not listed | Binghamton | New York | 13901 | — |
| Not listed | Endwell | New York | 13760 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Rochester | New York | 14621 | — |
| Not listed | Cary | North Carolina | 27518 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Cincinnati | Ohio | 45249 | — |
| Not listed | Allentown | Pennsylvania | 18102 | — |
| Not listed | Bensalem | Pennsylvania | 19020 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Fort Worth | Texas | 76107 | — |
| Not listed | Fort Worth | Texas | 76135 | — |
| Not listed | Galveston | Texas | 77555 | — |
| Not listed | San Angelo | Texas | 76904 | — |
| Not listed | Salt Lake City | Utah | 84109 | — |
| Not listed | Salt Lake City | Utah | 84121 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | Seattle | Washington | 98101 | — |
| Not listed | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00772109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00772109 live on ClinicalTrials.gov.